vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Massimo Group (MAMO). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $21.0M, roughly 1.5× Massimo Group). Massimo Group runs the higher net margin — 9.5% vs -32.1%, a 41.6% gap on every dollar of revenue. On growth, Massimo Group posted the faster year-over-year revenue change (15.7% vs -4.5%). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -16.5%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Massimo Dutti, S.A. is a Spanish premium clothing retailer specializing in cashmere and wool products, established in 1985 and owned by Spanish multinational company Inditex, the parent company of Zara, Pull&Bear, and other brands.
LFCR vs MAMO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $21.0M |
| Net Profit | $-10.0M | $2.0M |
| Gross Margin | 25.0% | 41.5% |
| Operating Margin | -9.9% | 13.1% |
| Net Margin | -32.1% | 9.5% |
| Revenue YoY | -4.5% | 15.7% |
| Net Profit YoY | -52.0% | 215.0% |
| EPS (diluted) | $-0.29 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $21.0M | ||
| Q3 25 | $31.1M | $17.0M | ||
| Q2 25 | — | $18.9M | ||
| Q1 25 | $35.2M | $14.9M | ||
| Q4 24 | $32.6M | $18.2M | ||
| Q3 24 | $24.7M | $25.6M | ||
| Q2 24 | — | $35.4M | ||
| Q1 24 | $35.7M | $30.2M |
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-10.0M | $1.5M | ||
| Q2 25 | — | $77.7K | ||
| Q1 25 | $-14.8M | $-2.1M | ||
| Q4 24 | $-6.6M | $-1.7M | ||
| Q3 24 | $-16.2M | $-2.5M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | $15.6M | $3.2M |
| Q4 25 | — | 41.5% | ||
| Q3 25 | 25.0% | 42.0% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | 28.0% | 28.4% | ||
| Q4 24 | 34.0% | 19.6% | ||
| Q3 24 | 21.8% | 27.2% | ||
| Q2 24 | — | 32.5% | ||
| Q1 24 | 33.3% | 34.7% |
| Q4 25 | — | 13.1% | ||
| Q3 25 | -9.9% | 10.5% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | -25.7% | -18.2% | ||
| Q4 24 | -6.0% | -15.4% | ||
| Q3 24 | -46.9% | 1.2% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | -2.5% | 13.2% |
| Q4 25 | — | 9.5% | ||
| Q3 25 | -32.1% | 9.0% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | -42.0% | -14.0% | ||
| Q4 24 | -20.2% | -9.5% | ||
| Q3 24 | -65.7% | -9.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | 43.8% | 10.6% |
| Q4 25 | — | $0.05 | ||
| Q3 25 | $-0.29 | $0.04 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | $-0.47 | $-0.05 | ||
| Q4 24 | $-0.25 | $-0.05 | ||
| Q3 24 | $-0.53 | $-0.06 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | $0.42 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $5.8M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $23.7M |
| Total Assets | $235.2M | $51.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.8M | ||
| Q3 25 | $18.9M | $2.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | $3.0M | ||
| Q4 24 | $9.5M | $10.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $23.7M | ||
| Q3 25 | $-10.5M | $21.7M | ||
| Q2 25 | — | $20.2M | ||
| Q1 25 | $2.2M | $19.9M | ||
| Q4 24 | $15.4M | $21.7M | ||
| Q3 24 | $-3.9M | $22.5M | ||
| Q2 24 | — | $24.7M | ||
| Q1 24 | $17.7M | $18.1M |
| Q4 25 | — | $51.4M | ||
| Q3 25 | $235.2M | $44.4M | ||
| Q2 25 | — | $45.9M | ||
| Q1 25 | $237.7M | $46.4M | ||
| Q4 24 | $255.4M | $54.9M | ||
| Q3 24 | $246.8M | $57.1M | ||
| Q2 24 | — | $49.9M | ||
| Q1 24 | $246.2M | $47.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $4.0M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | 2.01× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.0M | ||
| Q3 25 | $1.8M | $633.2K | ||
| Q2 25 | — | $-1.4M | ||
| Q1 25 | $1.2M | $-3.3M | ||
| Q4 24 | $-6.1M | $9.1M | ||
| Q3 24 | $-613.0K | $4.7M | ||
| Q2 24 | — | $-6.5M | ||
| Q1 24 | $-1.4M | $-637.0K |
| Q4 25 | — | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | $9.0M | ||
| Q3 24 | $-4.0M | $4.6M | ||
| Q2 24 | — | $-6.7M | ||
| Q1 24 | $-7.8M | $-741.4K |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | 49.7% | ||
| Q3 24 | -16.3% | 18.1% | ||
| Q2 24 | — | -19.0% | ||
| Q1 24 | -21.8% | -2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | 0.2% | ||
| Q3 24 | 13.9% | 0.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | 17.8% | 0.3% |
| Q4 25 | — | 2.01× | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | -17.92× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.30× | ||
| Q1 24 | -0.09× | -0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
MAMO
Segment breakdown not available.
